Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
ALL MEDICAL CODES IN CATEGORY Oncology - Current Disease Status

2025 HCPCS code G9073

Invasive female breast cancer, predominantly adenocarcinoma, Stage IIIA-IIIB (not T3, N1, M0), ER/PR positive, no progression/recurrence/metastasis, not ductal carcinoma in situ.

2025 HCPCS code G9107

Oncology - other

2025 HCPCS code G9108

Provides information on the disease status of metastatic pancreatic adenocarcinoma with unknown extent of progression; used in a 2006 Medicare demonstration project.

2025 HCPCS code G9098

Cancer of the esophagus, adenocarcinoma or squamous cell carcinoma, metastatic, recurrent, or progressive disease status.

2025 HCPCS code G9101

Provides information on the disease status of gastric adenocarcinoma, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9107

肿瘤学-其他

2025 HCPCS code G9087

환자의 결장암 상태 (침윤성 선암종, M1 전이, 진행성 질환) 를 나타내는 메디케어 시범 프로젝트의 보고 코드

2025 HCPCS code G9087

Mã báo cáo cho một dự án trình diễn Medicare, cho biết tình trạng ung thư ruột kết của bệnh nhân (ung thư biểu mô tuyến xâm lấn, di căn M1, bệnh tiến triển).

2025 HCPCS code G9087

Code de déclaration pour un projet de démonstration de Medicare, indiquant l'état du patient en matière de cancer du côlon (adénocarcinome invasif, métastase M1, maladie évolutive).

2025 HCPCS code G9073

浸润性女性乳腺癌,主要是腺癌,<a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025">IIIA-II</a> <a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">B</a> 期(非T3、N1、M0),<a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">ER</a>/<a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">PR</a> 阳性,无进展/复发/转移,非导管原位癌。

2025 HCPCS code G9073

Invasiver Brustkrebs bei Frauen, vorwiegend Adenokarzinom, Stadium <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025"><a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIA-IIIB</a></a> (nicht T3, N1, M0), <a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">ER/PR-positiv</a>, keine <a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">Progression/Rezidiv/Metastasierung</a>, kein duktales Karzinom in situ.

2025 HCPCS code G9073

<a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">Инвазивный рак молочной железы у женщин, преимущественно аденокарцинома, стадии <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025"><a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIA-IIIB</a></a> (не T3, N1, M0), положительный результат на <a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">ER/PR</a>, без прогрессирования, рецидива или метастазирования, карцинома протоков на месте не обнаружена.</a>

2025 HCPCS code G9073

Ung thư vú nữ xâm lấn, chủ yếu là ung thư biểu mô tuyến, giai đoạn <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025">IIIA</a> - <a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIB</a> (không T3, N1, M0), ER/ <a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">PR dương tính, không tiến triể <a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">n/</a> tái pháp/di</a> căn, không ung thư biểu mô ống dẫn tại chỗ.

2025 HCPCS code G9073

Cancer invasif du sein féminin, principalement adénocarcinome, stade <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025">IIIA - <a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIB</a></a> (non T3, N1, M0), <a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">ER/PR</a> positif, pas de <a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">progression/récidive/métastase</a>, pas de carcinome canalaire in situ.

2025 HCPCS code G9073

Cáncer de mama femenino invasivo, predominantemente adenocarcinoma, estadio <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025">IIIA a <a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIB</a></a> (no T3, N1, M0), ER/ <a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">PR</a> positivo, sin <a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">progresión/recidivación/metástasis</a>, no carcinoma ductal in situ.

2025 HCPCS code G9073

Ang nasasakay na kanser sa suso ng babae, kadalasang adenocarcinoma, Stage <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025">IIIA</a> - <a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIB</a> (hindi T3, N1, M0), ER/ <a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">PR</a> positibo, walang progresyon/ <a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">paul</a> rence/metastasis, hindi ductal carcinoma in situ.

2025 HCPCS code G9073

<a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025"><a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">침윤성 여성 유방암, 주로 선암종, <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025">IIIA기</a> - <a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIB (T3, N1, M0 아님), ER/PR</a> 양성, 진행/재발/전이 없음, 관상피내암이 아님.</a></a>

2025 HCPCS code G9073

سرطان الثدي الأنثوي الغازي، في الغالب السرطان الغدي، المرحلة <a href="../medical-coding/reference/IIIA" target="_blank" title="Medical Code IIIA 2025">IIIA - <a href="../medical-coding/reference/IIIB" target="_blank" title="Medical Code IIIB 2025">IIIB</a></a> (ليس T3، N1، M0)، <a href="../medical-coding/reference/PR" target="_blank" title="Medical Code PR 2025">ER/PR</a> إيجابي، لا يوجد تقدم/تكرار/ورم خبيث، وليس <a href="../medical-coding/reference/ER" target="_blank" title="Medical Code ER 2025">سرطان</a> قنوي في الموقع.

2025 HCPCS code G9128

Multiple Myeloma, Stage IA

2025 HCPCS code G9112

This HCPCS code reports information on head and neck cancer status, including staging, for a specific Medicare demonstration project in 2006.

2025 HCPCS code G9093

Rectal cancer, limited to invasive, predominantly adenocarcinoma, initial extent of disease T4, any N, M0, before neoadjuvant therapy, no evidence of progression, recurrence, or metastases.

2025 HCPCS code G9133

G9133 reports the disease status of hormone-responsive prostate adenocarcinoma with metastases, used in a 2006 Medicare demonstration project.

2025 HCPCS code G9087

Reporting code for a Medicare demonstration project, indicating a patient's colon cancer status (invasive adenocarcinoma, M1 metastasis, progressive disease).

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">الورم النقوي المتعدد، المرحلة IA</a>

2025 HCPCS code G9112

이 HCPCS 코드는 2006년 특정 메디케어 시범 프로젝트의 병기 진단을 포함한 두경부암 상태에 대한 정보를 보고합니다.

2025 HCPCS code G9112

Dieser HCPCS-Code enthält Informationen zum Status von Kopf- und Halskrebs, einschließlich der Stadieneinteilung, für ein bestimmtes Medicare-Demonstrationsprojekt im Jahr 2006.

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">Множественная миелома, стадия IA</a>

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">多发性骨髓瘤,IA 阶段</a>

2025 HCPCS code G9133

<a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">G9133</a> 报告了带有转移的激素反应性前列腺癌的疾病状况,该癌用于 2006 年的医疗保险示范项目。

2025 HCPCS code G9133

<a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">يُبلغ G9133</a> عن حالة مرض سرطان البروستاتا المستجيب للهرمونات مع النقائل، والذي تم استخدامه في مشروع تجريبي لبرنامج Medicare لعام 2006.

2025 HCPCS code G9133

<a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">G9133</a> сообщает о состоянии гормоночувствительной аденокарциномы простаты с метастазами, что было использовано в демонстрационном проекте Medicare 2006 года.

2025 HCPCS code G9133

Le <a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">G9133</a> rend compte de l'état de la maladie d'un adénocarcinome de la prostate hormono-sensible avec métastases, utilisé dans le cadre d'un projet de démonstration Medicare en 2006.

2025 HCPCS code G9133

<a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">G9133</a> báo cáo tình trạng bệnh của ung thư biểu mô tuyến tiền liệt đáp ứng với hormone có di căn, được sử dụng trong một dự án trình diễn Medicare năm 2006.

2025 HCPCS code G9133

<a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">G9133</a> berichtet über den Krankheitsstatus eines hormonresponsiven Prostataadenokarzinoms mit Metastasen, das 2006 in einem Medicare-Demonstrationsprojekt verwendet wurde.

2025 HCPCS code G9133

El <a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">G9133</a> informa sobre el estado patológico del adenocarcinoma de próstata con metástasis que responde a las hormonas, utilizado en un proyecto de demostración de Medicare en 2006.

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">Maramihang Myeloma, Stage IA</a>

2025 HCPCS code G9133

<a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">G9133</a> 보고서는 2006년 메디케어 시범 프로젝트에 사용된 전이를 동반한 호르몬 반응성 전립선 선암종의 질병 상태를 보고합니다.

2025 HCPCS code G9133

<a href="../medical-coding/reference/G9133" target="_blank" title="Medical Code G9133 2025">Iniulat ng G9133 ang kat</a> ayuan ng sakit ng prostate adenocarcinoma na tumutugon sa hormone na may metastases, na ginamit sa isang proyekto ng pagpapakita ng Medicare noong 2006.

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">Mieloma múltiple, estadio IA</a>

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">Myélome multiple, stade IA</a>

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">다발성 골수종, 단계 IA</a>

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">Đa u tủy, Giai đoạn IA</a>

2025 HCPCS code G9128

<a href="../medical-coding/reference/IA" target="_blank" title="Medical Code IA 2025">Multiples Myelom, Stadium IA</a>

2025 HCPCS code G9112

Этот код HCPCS содержит информацию о состоянии рака головы и шеи, включая стадию, для конкретного демонстрационного проекта Medicare в 2006 году.

2025 HCPCS code G9107

علم الأورام - أخرى

2025 HCPCS code G9107

Ung thư - khác

2025 HCPCS code G9112

Este código HCPCS proporciona información sobre el estado del cáncer de cabeza y cuello, incluida la estadificación, para un proyecto de demostración específico de Medicare en 2006.

2025 HCPCS code G9112

该HCPCS守则报告了有关头颈部癌症状况的信息,包括2006年特定医疗保险示范项目的分期。

2025 HCPCS code G9107

Oncologie - autres

2025 HCPCS code G9112

يقدم رمز HCPCS هذا معلومات عن حالة سرطان الرأس والرقبة، بما في ذلك تحديد المرحلة، لمشروع تجريبي محدد لبرنامج Medicare في عام 2006.